CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 232 enrolled
Drug / intervention
Health-IT +/- Scheduled Follow Upother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03564626
NCT03564626N/ACompleted
CompareCT.gov

Health IT Generated PROs to Improve Outcomes in Cirrhosis

Virginia Commonwealth University·interventional·Posted Jun 21, 2018·Updated Sep 17, 2025

In Brief

A clinical study evaluating Health-IT +/- Scheduled Follow Up for Cirrhosis. Completed, enrolled 232 participants across 3 sites.

Detailed Summary

SPECIFIC AIM 1: To evaluate in a multi-center, randomized trial the effectiveness of PROs elicited using PatientBuddy and EncephalApp on the prevention of avoidable 30 day readmissions in patients with cirrhosis and their caregivers compared to standard of care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCirrhosis
CountriesUnited States
CollaboratorsAgency for Healthcare Research and Quality (AHRQ)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 21, 2018
Enrollment StartJun 22, 2018
Primary CompletionApr 22, 2024
Study CompletionMay 22, 2024
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 8.0 years ago

Interventions

Health-IT +/- Scheduled Follow Upother

* Training patient and caregiver on Patient Buddy and EncephalApp * Counseling regarding readmission * Daily contact through app * Standard of care counseling regarding readmission and discharge instructions * Follow up phone calls at Week 1 and Week 3 * In-person follow up visits at Week 2 and Week 4